Logo image of LOT

LOTUS TECHNOLOGY INC (LOT) Stock Fundamental Analysis

NASDAQ:LOT - Nasdaq - US54572F1012 - ADR - Currency: USD

2.36  -0.02 (-0.84%)

Fundamental Rating

1

LOT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 37 industry peers in the Automobiles industry. LOT has a bad profitability rating. Also its financial health evaluation is rather negative. LOT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year LOT has reported negative net income.
In the past year LOT has reported a negative cash flow from operations.
LOT Yearly Net Income VS EBIT VS OCF VS FCFLOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -200M -400M -600M

1.2 Ratios

LOT has a Return On Assets (-25.95%) which is in line with its industry peers.
Industry RankSector Rank
ROA -25.95%
ROE N/A
ROIC N/A
ROA(3y)-14.05%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LOT Yearly ROA, ROE, ROICLOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

1.3 Margins

LOT has a better Gross Margin (18.61%) than 78.38% of its industry peers.
LOT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LOT Yearly Profit, Operating, Gross MarginsLOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -20 -40 -60 -80 -100

1

2. Health

2.1 Basic Checks

LOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
LOT has less shares outstanding than it did 1 year ago.
LOT has a worse debt/assets ratio than last year.
LOT Yearly Shares OutstandingLOT Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 200M 400M 600M 800M
LOT Yearly Total Debt VS Total AssetsLOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

LOT has an Altman-Z score of -2.14. This is a bad value and indicates that LOT is not financially healthy and even has some risk of bankruptcy.
LOT has a Altman-Z score (-2.14) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.14
ROIC/WACCN/A
WACC6.38%
LOT Yearly LT Debt VS Equity VS FCFLOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 200M -200M -400M -600M -800M

2.3 Liquidity

A Current Ratio of 0.50 indicates that LOT may have some problems paying its short term obligations.
LOT has a worse Current ratio (0.50) than 75.68% of its industry peers.
LOT has a Quick Ratio of 0.50. This is a bad value and indicates that LOT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.35, LOT is not doing good in the industry: 72.97% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.5
Quick Ratio 0.35
LOT Yearly Current Assets VS Current LiabilitesLOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500M 1B 1.5B

3

3. Growth

3.1 Past

The earnings per share for LOT have decreased strongly by -30116.99% in the last year.
EPS 1Y (TTM)-30116.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8109.58%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

LOT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.35% yearly.
The Revenue is expected to grow by 50.17% on average over the next years. This is a very strong growth
EPS Next Y-32.38%
EPS Next 2Y4.5%
EPS Next 3Y14.11%
EPS Next 5Y15.35%
Revenue Next Year41.67%
Revenue Next 2Y38.31%
Revenue Next 3Y53.21%
Revenue Next 5Y50.17%

3.3 Evolution

LOT Yearly Revenue VS EstimatesLOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 1B 2B 3B
LOT Yearly EPS VS EstimatesLOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

0

4. Valuation

4.1 Price/Earnings Ratio

LOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LOT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LOT Price Earnings VS Forward Price EarningsLOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LOT Per share dataLOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

LOT's earnings are expected to grow with 14.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.5%
EPS Next 3Y14.11%

0

5. Dividend

5.1 Amount

LOT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LOTUS TECHNOLOGY INC

NASDAQ:LOT (7/18/2025, 8:00:01 PM)

2.36

-0.02 (-0.84%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)05-30 2025-05-30
Earnings (Next)08-26 2025-08-26
Inst Owners8.16%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.60B
Analysts45
Price Target3.06 (29.66%)
Short Float %0.34%
Short Ratio3.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.92
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.9
EYN/A
EPS(NY)-0.84
Fwd EYN/A
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS0.81
BVpS-1.21
TBVpS-1.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.95%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.61%
FCFM N/A
ROA(3y)-14.05%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 388.88%
Cap/Sales 38.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.5
Quick Ratio 0.35
Altman-Z -2.14
F-Score3
WACC6.38%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30116.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8109.58%
EPS Next Y-32.38%
EPS Next 2Y4.5%
EPS Next 3Y14.11%
EPS Next 5Y15.35%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year41.67%
Revenue Next 2Y38.31%
Revenue Next 3Y53.21%
Revenue Next 5Y50.17%
EBIT growth 1Y-8544.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year7.58%
EBIT Next 3Y22.24%
EBIT Next 5Y20.29%
FCF growth 1Y-101704%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-65481.7%
OCF growth 3YN/A
OCF growth 5YN/A